• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Recent Advances in Precision-Based Early Screening for Hepatocellular Carcinoma

DOI: 10.12201/bmr.202512.00013
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Hepatocellular carcinoma (HCC), as the fourth leading cause of cancer-related mortality globally, highlights that early diagnosis is pivotal for improving prognosis. Relevant professional associations recommend differentiated screening for high-risk populations with chronic liver diseases, yet current strategies confront multiple challenges. The insufficient sensitivity of traditional HCC screening tests leads to persistently high missed diagnosis rates for early-stage HCC. Concurrently, the high-risk population is expanding from viral liver diseases to metabolic liver diseases, triggering a surge in screening demands and the attenuation of efficacy of previous indicators. This article focuses on precision research for early HCC screening, elaborating in detail on the applications of emerging biomarkers and liquid biopsy technologies in non-invasive biomarkers. It explores the implementation of personalized precision screening strategies by comprehensively integrating multiple detection indicators, and discusses the efficacy of comprehensive screening strategies and risk stratification in addressing the issues of drastically expanded screening scope (due to the shift of high-risk populations from viral to metabolic liver diseases) and the inadequate effectiveness of previous detection indicators. It is proposed that future research should prioritize clinical validation of new technologies, development of precision screening protocols, economic analysis, and multidisciplinary collaboration to improve future HCC prognosis and alleviate the social medical burden.

    Key words: Hepatocellular Carcinoma; Cirrhosis; High-Risk Population; Early Surveillance; Risk-Stratified Precision Surveillance

    Submit time: 4 December 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • ChenYu, libowen, yangjinhua, liuyang, weiyunwei. Research progress and prospect of targeted therapy of microflora in hepatocellular carcinoma. 2024. doi: 10.12201/bmr.202412.00033

    He Yushan, Wang Bingsen, Gao Dongping. Research Progress on the Value of Functional Near-Infrared Spectroscopy in the Early Screening of Autism Spectrum Disorder. 2025. doi: 10.12201/bmr.202512.00058

    Wang Ya-jing, Peng Pei, Zhang Xue. Exploration of the Pathogenic characteristics of Hepatocellular Carcinoma Liver Depression and Spleen Deficiency Based on the. 2025. doi: 10.12201/bmr.202506.00030

    Analysis of the Distribution of High-risk Human Papillomavirus Subtypes and High-risk Factors among Women in Jiaxing, Zhejiang Province. 2025. doi: 10.12201/bmr.202502.00011

    ZHANG Xiaoling, CHEN Kun. The value of systemic inflammatory response index, lactate dehydrogenase and glutamic oxalacetic transaminase in identifying the high-risk population of adult fulminant myocarditis. 2024. doi: 10.12201/bmr.202410.00070

    李明峻, Zhai Ning. Advances and prospects of artificial intelligence in precision phenotyping of heart failure. 2025. doi: 10.12201/bmr.202512.00030

    yangxiaoyan. Predictive Value of First-Trimester Serological Markers PAPP-A and Free-hCGβ Combined with Gestational Weight Gain for Fetal Growth Restriction
    ????????????? Yang Wenying1? Yang Xiaoyan▲. 2025. doi: 10.12201/bmr.202505.00018

    SiWei, XuTing, LinJiayue, Cao Wenting, ZhuAiyong. A review of artificial intelligence technology in the screening of cognitive impairment. 2024. doi: 10.12201/bmr.202407.00048

    ZHAO Yueshu, Wang rui, Liu Ling, Li jianing, Feng Chunyu, Wang Suzhen. A Comparative Analysis of Prenatal Screening Choices: ART versus Natural Conception. 2025. doi: 10.12201/bmr.202512.00015

    贺明敏, Wang Lingli. Discussion on the Etiology, Pathogenesis, Prevention and Treatment of Persistent High-Risk HPV Infection Based on “Latent Pathogen” Theory. 2025. doi: 10.12201/bmr.202510.00027

  • ID Submit time Number Download
    1 2025-09-15

    10.12201/bmr.202512.00013V1

    Download
  • Public  Anonymous  To author only

Get Citation

LU Ming, ZHONG Peisong, REN Honglei, YIN Fanglan. Recent Advances in Precision-Based Early Screening for Hepatocellular Carcinoma. 2025. biomedRxiv.202512.00013

Article Metrics

  • Read: 125
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误